MCID: PRN021
MIFTS: 49

Paranasal Sinus Disease malady

Categories: Respiratory diseases

Aliases & Classifications for Paranasal Sinus Disease

Aliases & Descriptions for Paranasal Sinus Disease:

Name: Paranasal Sinus Disease 12 14
Paranasal Sinus Diseases 42 69
Disorder of Nasal Sinus 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1352
MeSH 42 D010254
NCIt 47 C26843
SNOMED-CT 64 195823002 7393007
UMLS 69 C0030469

Summaries for Paranasal Sinus Disease

MalaCards based summary : Paranasal Sinus Disease, also known as paranasal sinus diseases, is related to myoglobinuria recurrent and dahlberg borer newcomer syndrome. An important gene associated with Paranasal Sinus Disease is IL5 (Interleukin 5), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Amoxicillin and Cefditoren have been mentioned in the context of this disorder. Affiliated tissues include eye, bone and t cells, and related phenotypes are hematopoietic system and homeostasis/metabolism

Wikipedia : 71 Paranasal sinuses are a group of four paired air-filled spaces that surround the nasal cavity. The... more...

Related Diseases for Paranasal Sinus Disease

Diseases related to Paranasal Sinus Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 179)
id Related Disease Score Top Affiliating Genes
1 myoglobinuria recurrent 10.3 IFNG IL4
2 dahlberg borer newcomer syndrome 10.3 IL13 IL5
3 tubular renal disease-cardiomyopathy syndrome 10.3 IL10 IL4
4 spastic paraplegia 3a, autosomal dominant 10.3 IL13 IL4 IL5
5 gastroschisis abdominal wall defects, included 10.3 IFNG IL5
6 bone peripheral neuroepithelioma 10.3 IL13 IL4 IL5
7 luminal breast carcinoma 10.3 IL13 IL4 IL5
8 lactose intolerance 10.3 IL13 IL4 IL5
9 multiple epiphyseal dysplasia due to collagen 9 anomaly 10.3 IFNG IL4 IL5
10 urethral intrinsic sphincter deficiency 10.3 IFNG IL4 IL5
11 askin's tumor 10.3 IL13 IL4 IL5
12 trachea leiomyoma 10.3 IL13 IL4 IL5
13 visceral steatosis 10.3 IL13 IL4 IL5
14 lymphocytic gastritis 10.3 IL13 IL4 IL5
15 crustacean allergy 10.3 IFNG IL13 IL4
16 cutaneous fibrous histiocytoma 10.3 IFNG IL4 IL5
17 asymptomatic neurosyphilis 10.3 IFNG IL10 IL4
18 goat milk allergy 10.3 IL10 IL13 IL4
19 isolated klippel-feil syndrome 10.3 IFNG IL4 IL5
20 ethmoid sinusitis 10.3 IL13 IL4 IL5
21 tungiasis 10.3 IFNG IL10 IL4
22 centronuclear myopathy 5 10.3 IFNG IL10 IL4
23 inflamed seborrheic keratosis 10.3 IL13 IL4 IL5
24 multiple mitochondrial dysfunctions syndrome 10.3 IFNG IL10 IL5
25 neurotic disorder 10.3 IFNG IL10 IL4
26 myofibroma 10.3 IFNG IL10 IL13
27 refractory celiac disease 10.3 IL10 TGFB1
28 ectodermal dysplasia bartalos type 10.3 IFNG IL10 IL4
29 autosomal recessive congenital methemoglobinemia 10.2 IFNG IL13 IL5
30 patellar tendinitis 10.2 IL13 IL4 IL5
31 acute myeloid leukemia with recurrent genetic anomaly 10.2 IFNG IL10 IL4
32 proximal symphalangism 10.2 IFNG IL10 IL4
33 colon adenocarcinoma 10.2 IL10 IL4 IL5
34 acute dacryoadenitis 10.2 IL13 IL4 IL5
35 common cold 10.2 PLAU PLAUR
36 mansonelliasis 10.2 IFNG IL10 IL5
37 multiple carboxylase deficiency 10.2 IFNG IL4 IL5
38 lagophthalmos 10.2 IL10 IL4
39 smooth muscle tumor 10.2 IL13 IL17A IL5
40 acute gonococcal prostatitis 10.2 IFNG IL13 IL4 IL5
41 blue toe syndrome 10.2 IFNG IL10 IL4
42 hydrophthalmos 10.2 IFNG IL13 IL4 IL5
43 indian plum allergy 10.2 IL10 IL13 IL4 IL5
44 thyroid hyalinizing trabecular adenoma 10.2 IFNG IL13 IL4 IL5
45 abnormal retinal correspondence 10.2 IFNG IL10 IL4 IL5
46 parkinson disease 11 10.2 IFNG IL10 IL17A
47 papillary adenocarcinoma 10.2 IL10 IL13 TGFB1
48 cockayne syndrome, type b 10.2 IFNG IL10 IL4 IL5
49 malignant oculomotor nerve tumor 10.2 IFNG IL13 TGFB1
50 tuberculosis 10.2 IL10 IL17A IL4

Graphical network of the top 20 diseases related to Paranasal Sinus Disease:



Diseases related to Paranasal Sinus Disease

Symptoms & Phenotypes for Paranasal Sinus Disease

MGI Mouse Phenotypes related to Paranasal Sinus Disease:

44 (show all 19)
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.37 ALOX5 CD79A GATA3 IFNG IL10 IL13
2 homeostasis/metabolism MP:0005376 10.36 ALOX5 CD79A GATA3 IFNG IL10 IL13
3 growth/size/body region MP:0005378 10.35 FLNC GATA3 IFNG IL10 IL13 IL17A
4 immune system MP:0005387 10.34 PLAUR SERPINE1 TGFB1 ALOX5 CD79A GATA3
5 cellular MP:0005384 10.32 ALOX5 CD79A GATA3 IFNG IL10 IL13
6 cardiovascular system MP:0005385 10.24 ALOX5 FLNC GATA3 IFNG IL10 PLAU
7 digestive/alimentary MP:0005381 10.21 GATA3 IFNG IL10 IL13 IL17A IL4
8 mortality/aging MP:0010768 10.17 FLNC GATA3 IFNG IL10 IL13 IL17A
9 endocrine/exocrine gland MP:0005379 10.15 GATA3 IL13 IL17A IL4 PLAU TGFB1
10 craniofacial MP:0005382 10.11 GATA3 IFNG IL10 IL17A IL4 PLAU
11 liver/biliary system MP:0005370 10.11 IL4 IL5 PLAU PLAUR SERPINE1 TGFB1
12 integument MP:0010771 10.08 TGFB1 FLNC GATA3 IFNG IL10 IL13
13 muscle MP:0005369 10.01 FLNC GATA3 IFNG IL10 IL13 PLAU
14 neoplasm MP:0002006 9.91 IL10 IL5 PLAU SERPINE1 TGFB1 CD79A
15 no phenotypic analysis MP:0003012 9.87 CD79A GATA3 IFNG IL10 IL13 IL17A
16 renal/urinary system MP:0005367 9.86 CD79A GATA3 IFNG IL17A IL4 PLAUR
17 reproductive system MP:0005389 9.76 GATA3 IFNG IL10 IL13 IL4 IL5
18 respiratory system MP:0005388 9.73 PLAUR SERPINE1 TGFB1 FLNC IFNG IL10
19 skeleton MP:0005390 9.28 ALOX5 GATA3 IFNG IL10 IL13 IL17A

Drugs & Therapeutics for Paranasal Sinus Disease

Drugs for Paranasal Sinus Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 696)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 26787-78-0 33613 2171
2
Cefditoren Approved Phase 4 117467-28-4, 104145-95-1 9571074 9870843
3
Montelukast Approved Phase 4 158966-92-8 5281040
4
Amiodarone Approved, Investigational Phase 4,Phase 3,Phase 2 1951-25-3 2157
5
Benzocaine Approved Phase 4,Phase 3,Phase 1,Phase 2 1994-09-7, 94-09-7 2337
6
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1 2216-51-5 16666
7
Digoxin Approved Phase 4,Phase 2,Phase 3 20830-75-5 30322 2724385
8
Propafenone Approved Phase 4 54063-53-5 4932
9
Sotalol Approved Phase 4,Phase 3 959-24-0, 3930-20-9 5253
10
Budesonide Approved Phase 4,Phase 3,Phase 2,Phase 1 51333-22-3 63006 5281004
11
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 299-42-3 9294
12
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 90-82-4 7028
13
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
14
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
15
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
16
Ibutilide Approved Phase 4 122647-32-9, 122647-31-8 60753
17
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 137-58-6 3676
18
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Phase 1 103-90-2 1983
19
Dextromethorphan Approved Phase 4 125-71-3 5360696 5362449
20
Guaifenesin Approved, Vet_approved Phase 4,Phase 2 93-14-1 3516
21
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
22
Cocaine Approved, Illicit Phase 4,Phase 3,Phase 2 50-36-2 5760 446220
23
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
24
Triamcinolone Approved, Vet_approved Phase 4,Phase 3 124-94-7 31307
25
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
26
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
27
Remifentanil Approved Phase 4 132875-61-7 60815
28
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 55185 53477736 447043
29
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
30
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 83-43-2 6741
31
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-24-8 5755
32
Cefdinir Approved Phase 4 91832-40-5 6915944
33
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757 53477783
34
Ethinyl Estradiol Approved Phase 4,Phase 3 57-63-6 5991
35
Moxifloxacin Approved, Investigational Phase 4,Phase 3 354812-41-2, 151096-09-2 152946
36
Norgestimate Approved Phase 4,Phase 3 35189-28-7 6540478
37
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 100986-85-4 149096
38
Ofloxacin Approved Phase 4,Phase 3,Phase 2 82419-36-1 4583
39
Telithromycin Approved Phase 4,Phase 3 191114-48-4 5462516
40
Ethanol Approved Phase 4,Phase 2 64-17-5 702
41
Almotriptan Approved, Investigational Phase 4 154323-57-6, 181183-52-8 123606
42
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 75614-87-8, 51-45-6 774
43
Omalizumab Approved, Investigational Phase 4,Phase 3,Phase 2 242138-07-4
44
Antazoline Approved Phase 4 91-75-8 2200
45
Magnesium Sulfate Approved, Vet_approved Phase 4 7487-88-9 24083
46
Dofetilide Approved Phase 4 115256-11-6 71329
47
Quinidine Approved Phase 4 56-54-2 441074
48
Nicotine Approved Phase 4 54-11-5 942 89594
49
Mupirocin Approved, Investigational, Vet_approved Phase 4 12650-69-0 446596
50
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 2180-92-9, 38396-39-3 2474

Interventional clinical trials:

(show top 50) (show all 1177)
id Name Status NCT ID Phase
1 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4
2 Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis Unknown status NCT01553006 Phase 4
3 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4
4 Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias Unknown status NCT01717469 Phase 4
5 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Unknown status NCT01850277 Phase 4
6 Evaluation of a Lateral Window Technique Augmentation for Maxillary Sinus Using Ultrasound Activated Pins Unknown status NCT02449707 Phase 4
7 Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction Unknown status NCT02046044 Phase 4
8 Mode Evaluation in Sick Sinus Syndrome Trial (MODEST) Unknown status NCT00161551 Phase 4
9 Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Unknown status NCT01750775 Phase 4
10 Vernakalant Versus Flecainide: Atrial Contractility Unknown status NCT01646281 Phase 4
11 Line Versus Spot Ablation in Persistent Atrial Fibrillation Unknown status NCT00196157 Phase 4
12 Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation Unknown status NCT01070667 Phase 4
13 Efficacy of a Pacemaker Algorithm in Promotion of the Intrinsic Heart Activity. Unknown status NCT00156741 Phase 4
14 Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation Unknown status NCT00224341 Phase 4
15 Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation Unknown status NCT02145546 Phase 4
16 EvaluAtion of Predictive Value of Multisite Intracardiac EchoCardiography During Imaging of Structure and funCTION of Left Atrial Appendage in Comparison to Transesophageal Echocardiography Unknown status NCT01371279 Phase 4
17 Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation Unknown status NCT00196209 Phase 4
18 Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis Completed NCT00396162 Phase 4
19 The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device Completed NCT02079792 Phase 4
20 Treatment of Acute Sinusitis Completed NCT00377403 Phase 4
21 Sinuclean's Treatment Of Sinusitis' Symptoms Completed NCT00747747 Phase 4
22 Efficacy and Safety of Sinusitis Hevert SL Tablets Compared to Placebo in Adult Patients With Acute, Uncomplicated Rhinosinusitis Completed NCT02296814 Phase 4
23 Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel Completed NCT00554190 Phase 4
24 The PIO II Study of In-office Placement of a Steroid-eluting Sinus Implant Completed NCT02668302 Phase 4
25 Comparison of Topical Vasoconstriction in Endoscopic Sinus Surgery Completed NCT01706952 Phase 4
26 Hemostatic Matrix in Endoscopic Sinus Surgery Completed NCT00242437 Phase 4
27 Saline Irrigation After Surgery in Patients With Chronic Sinusitis Completed NCT01575223 Phase 4
28 Medicated Punctured-Glove-Finger Spacer Study Completed NCT01420471 Phase 4
29 Randomized Controlled Trial to Evaluate of Dexmedetomidine for the Effect on Operative Visibility in Patients Undergoing Endoscopic Sinus Surgery Completed NCT01569048 Phase 4
30 Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis Completed NCT01825408 Phase 4
31 Systemic Methylprednisolone in Chronic Rhinosinusitis Completed NCT01205984 Phase 4
32 Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life Completed NCT00147914 Phase 4
33 Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox Completed NCT00668304 Phase 4
34 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis Completed NCT00645073 Phase 4
35 Zmax Compared to Augmentin in Sinusitis Completed NCT00367120 Phase 4
36 CHOOSE : Telithromycin, Acute Bacterial Sinusitis Completed NCT00174694 Phase 4
37 Falls and Cardiovascular Events in Pacemaker Patients Completed NCT01037426 Phase 4
38 Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers Completed NCT00208065 Phase 4
39 The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis Completed NCT02696850 Phase 4
40 Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease Completed NCT01170611 Phase 4
41 Xolair in Patients With Chronic Sinusitis Completed NCT00117611 Phase 4
42 Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis Completed NCT03086070 Phase 4
43 Study of Asthma and Nasal Steroids Completed NCT01118312 Phase 4
44 Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation Completed NCT00845780 Phase 4
45 Spontaneous Atrio Ventricular Conduction Preservation Completed NCT00655213 Phase 4
46 Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing Completed NCT00286858 Phase 4
47 Comparison Between 2 Bilateral Internal Thoracic Artery Coronary Artery Bypass Grafting Configurations Completed NCT01666366 Phase 4
48 PANORAMA Observational Study Completed NCT00382525 Phase 4
49 DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients. Completed NCT00478933 Phase 4
50 Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation Completed NCT01527279 Phase 4

Search NIH Clinical Center for Paranasal Sinus Disease

Cochrane evidence based reviews: paranasal sinus diseases

Genetic Tests for Paranasal Sinus Disease

Anatomical Context for Paranasal Sinus Disease

MalaCards organs/tissues related to Paranasal Sinus Disease:

39
Eye, Bone, T Cells, Thyroid

Publications for Paranasal Sinus Disease

Articles related to Paranasal Sinus Disease:

(show all 48)
id Title Authors Year
1
Higher Body Mass Index and Increased Prevalence of Paranasal Sinus Disease. ( 26830349 )
2016
2
Pretransplant paranasal sinus disease is associated with a high incidence of transplant-related mortality in hematopoietic stem cell transplantation for children and adolescents. ( 27748554 )
2016
3
Association between diabetes and increased prevalence of paranasal sinus disease: a cross-sectional study in Japanese adults. ( 25728620 )
2015
4
Headaches caused by nasal and paranasal sinus disease. ( 24703542 )
2014
5
A stereological study on the correlation of inferior turbinate hypertrophy and paranasal sinus disease. ( 24389985 )
2014
6
The impact of a patient's age on the clinical presentation of inflammatory paranasal sinus disease. ( 23702318 )
2013
7
Prognosis for sixth nerve palsy arising from paranasal sinus disease. ( 24119609 )
2013
8
Clinical consensus statement: appropriate use of computed tomography for paranasal sinus disease. ( 23054429 )
2012
9
Equine paranasal sinus disease: a long-term study of 200 cases (1997-2009): treatments and long-term results of treatments. ( 21812808 )
2012
10
Ophthalmic manifestations of paranasal sinus disease: a clinical grading system. ( 22411699 )
2012
11
Equine paranasal sinus disease: a long-term study of 200 cases (1997-2009): ancillary diagnostic findings and involvement of the various sinus compartments. ( 21812807 )
2012
12
Paranasal sinus disease in horses. ( 21870345 )
2011
13
Complications of nose and paranasal sinus disease. ( 23272436 )
2011
14
The expression of fibrinolytic components in chronic paranasal sinus disease. ( 21711960 )
2011
15
Thyroid Eye Disease and Paranasal Sinus Disease. ( 20924307 )
2010
16
Paranasal sinus disease and sputum eosinophilia in prednisone-dependent asthma. ( 21144367 )
2010
17
T-cell regulation in chronic paranasal sinus disease. ( 18423831 )
2008
18
Significance of blood-tinged post-nasal drip in paranasal sinus disease. ( 17888198 )
2008
19
The incidence of concha bullosa and its relationship to nasal septal deviation and paranasal sinus disease. ( 15502150 )
2004
20
Headaches due to nasal and paranasal sinus disease. ( 15062525 )
2004
21
The role of leukotriene inhibitors in patients with paranasal sinus disease. ( 12923360 )
2003
22
CT characterization of inflammatory paranasal sinus disease in cystic fibrosis. ( 11972457 )
2002
23
Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. ( 11195032 )
2000
24
[Cytokines and chemokines in paranasal sinus diseases]. ( 10535064 )
1999
25
Relative value of MR imaging as compared with CT in the diagnosis of inflammatory paranasal sinus disease. ( 9885603 )
1999
26
Optic nerve blindness due to paranasal sinus disease. ( 10420111 )
1999
27
Use of standard radiography to diagnose paranasal sinus disease of asthmatic children in Taiwan: comparison with computed tomography. ( 10466541 )
1999
28
Correlation of clinical examination with computer tomography in paranasal sinus disease. ( 9209590 )
1997
29
Imaging in paranasal sinus disease. ( 9619203 )
1997
30
Imaging of paranasal sinus disease. ( 9168874 )
1997
31
Paranasal sinus disease in patients with cystic fibrosis. ( 8834282 )
1996
32
Malignant plasmacytoma appearing as invasive paranasal sinus disease after cardiac transplantation. ( 8883660 )
1996
33
Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. ( 8560170 )
1995
34
Nasal and paranasal sinus disease in patients with congenital velopharyngeal insufficiency. ( 8049050 )
1994
35
The prevalence of paranasal sinus disease in HIV infection and AIDS on cranial MR imaging. ( 8472478 )
1993
36
Inflammatory paranasal sinus disease in Bell's palsy demonstrated by magnetic resonance imaging. ( 8372929 )
1993
37
Paranasal sinus disease in HIV antibody positive patients. ( 8335314 )
1993
38
Effect of a topical vasoconstrictor on computed tomography of paranasal sinus disease. ( 8421421 )
1993
39
Endoscopic examination and treatment of paranasal sinus disease in 16 horses. ( 8116208 )
1993
40
Limited-slice CT in the evaluation of paranasal sinus disease in children. ( 1898816 )
1991
41
Paranasal sinus disease with intracranial extension: aspergillosis versus malignancy. ( 3131605 )
1988
42
Computed tomography in nasal and paranasal sinus disease. ( 6482629 )
1984
43
Comparison between transillumination and the roentgenogram in diagnosing paranasal sinus disease. ( 7451769 )
1981
44
Enzyme therapy in the triad of paranasal sinus disease, allergic asthmatic bronchitis, and bronchiectasis. ( 14446650 )
1959
45
The changing years: their impact upon the management of paranasal sinus disease. ( 13583895 )
1958
46
The changing years: their impact upon the management of paranasal sinus disease. ( 13647565 )
1958
47
Chronic paranasal sinus disease in adults; factors influencing treatment. ( 18124358 )
1949
48
Modern trends in diagnosis and treatment of paranasal sinus disease with particular reference to allergic manifestations. ( 20261616 )
1947

Variations for Paranasal Sinus Disease

Expression for Paranasal Sinus Disease

Search GEO for disease gene expression data for Paranasal Sinus Disease.

Pathways for Paranasal Sinus Disease

Pathways related to Paranasal Sinus Disease according to GeneCards Suite gene sharing:

(show all 46)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.98 ALOX5 CD79A GATA3 IFNG IL10 IL13
2
Show member pathways
13.63 ALOX5 IFNG IL10 IL13 IL17A IL4
3
Show member pathways
13.35 ALOX5 GATA3 IFNG IL10 IL13 IL17A
4
Show member pathways
13.28 FLNC IL10 IL13 IL17A IL4 IL5
5
Show member pathways
12.85 IFNG IL10 IL13 IL17A IL4 IL5
6
Show member pathways
12.58 ALOX5 CD79A IL13 IL4 IL5
7
Show member pathways
12.57 GATA3 IFNG IL10 IL13 IL17A IL4
8 12.55 ALOX5 CD79A GATA3 IFNG IL10 IL17A
9
Show member pathways
12.41 GATA3 IFNG IL10 IL17A IL4 IL5
10
Show member pathways
12.35 IFNG IL13 IL17A IL4 IL5 MUC5B
11
Show member pathways
12.32 ALOX5 IFNG IL4 SERPINE1
12 12.28 FLNC PLAU PLAUR TGFB1
13
Show member pathways
12.28 ALOX5 IFNG IL10 IL4 TGFB1
14
Show member pathways
12.23 IFNG IL10 IL13 IL4 IL5
15
Show member pathways
12.16 IFNG IL10 IL13 IL17A IL4 IL5
16 12.02 CD79A IFNG IL10 IL4 IL5
17 11.97 IFNG PLAU SERPINE1 TGFB1
18
Show member pathways
11.97 GATA3 IFNG IL10 IL17A TGFB1
19 11.95 IFNG IL4 TGFB1
20
Show member pathways
11.95 IFNG IL17A IL4 TGFB1
21 11.92 ALOX5 GATA3 IL10 IL13 IL17A IL4
22 11.85 IFNG IL10 TGFB1
23 11.84 GATA3 IFNG IL13 IL4 IL5
24 11.82 IFNG